TP53 and pancreatic neoplasm: In this study, we employed cell lines derived from a genetically engineered mouse model of pancreatic cancer with knock-in p53 alleles harbouring point mutations at codons R172H and R270H (equivalent to R175H and R273H in humans) to investigate the effects of mutant p53 on lipid metabolism.